Cover
Cover | Feb. 15, 2023 |
Document Information [Line Items] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Feb. 15, 2023 |
Entity File Number | 001-39650 |
Entity Registrant Name | Eucrates Biomedical Acquisition Corp. |
Entity Central Index Key | 0001822929 |
Entity Tax Identification Number | 00-0000000 |
Entity Incorporation, State or Country Code | D8 |
Entity Address, Address Line One | 250 West 55th Street |
Entity Address, Address Line Two | Suite 13D |
Entity Address, City or Town | New York |
Entity Address, State or Province | NY |
Entity Address, Postal Zip Code | 10019 |
City Area Code | 212 |
Local Phone Number | 710-5220 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | true |
Elected Not To Use the Extended Transition Period | false |
Ordinary shares, no par value [Member] | |
Document Information [Line Items] | |
Title of 12(b) Security | Ordinary shares, no par value |
Trading Symbol | EUCR |
Security Exchange Name | NASDAQ |
Warrant [Member] | |
Document Information [Line Items] | |
Title of 12(b) Security | Warrants, each whole warrant exercisable for one ordinary share at an exercise price of $11.50 per share |
Trading Symbol | EUCRW |
Security Exchange Name | NASDAQ |
Units, each consisting of one Ordinary Shares and one-third of one warrant [Member] | |
Document Information [Line Items] | |
Title of 12(b) Security | Units, each consisting of one Ordinary Shares and one-third of one warrant |
Trading Symbol | EUCRU |
Security Exchange Name | NASDAQ |